Skip to main content
Erschienen in: Heart and Vessels 8/2016

13.08.2015 | Original Article

Prevalence, implication, and determinants of worsening renal function after surgery for congenital heart disease

verfasst von: Hirofumi Saiki, Seiko Kuwata, Clara Kurishima, Yoichi Iwamoto, Hirotaka Ishido, Satoshi Masutani, Hideaki Senzaki

Erschienen in: Heart and Vessels | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

Accumulating data in adults indicate the prognostic importance of worsening renal function (WRF) during treatment of acute heart failure. Venous congestion appears to play a dominant role in WRF; however, data regarding WRF in children with congenital heart disease (CHD) are limited. The present study was conducted to elucidate the prevalence and characteristics of WRF after surgery for CHD in children. We also tested our hypothesis that, similar to adult heart failure, venous congestion is an important determinant of WRF independent of cardiac output in this population. Fifty-five consecutive pediatric patients who underwent cardiovascular surgery for CHD were studied (median age 0.7 years; range 3 days to 17 years). The degree of WRF was assessed by the difference between the maximum levels of postoperative serum creatinine (Cr) and preoperative serum Cr. There was a high prevalence of WRF in the present cohort: an increase in Cr level was observed in 47 patients (85 %) and a Cr increase ≥0.3 mg/dL was seen in 23 (42 %). Importantly, WRF was significantly associated with a worse clinical outcome of a longer stay in the intensive care unit and hospital (both p < 0.05), even after controlling for age and operative factors. In addition, multivariate regression analysis revealed that central venous pressure, rather than cardiac output, was an independent determinant of WRF. Postoperative management to relieve venous congestion may help ameliorate or prevent WRF and thereby improve outcomes in patients with CHD.
Literatur
1.
Zurück zum Zitat Liang KV, Williams AW, Greene EL, Redfield MM (2008) Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med 36:S75–S88CrossRefPubMed Liang KV, Williams AW, Greene EL, Redfield MM (2008) Acute decompensated heart failure and the cardiorenal syndrome. Crit Care Med 36:S75–S88CrossRefPubMed
2.
Zurück zum Zitat Takaya Y, Yoshihara F, Yokoyama H, Kanzaki H, Kitakaze M, Goto Y, Anzai T, Yasuda S, Ogawa H, Kawano Y (2014) Impact of onset time of acute kidney injury on outcomes in patients with acute decompensated heart failure. Heart Vessels. doi:10.1007/s00380-014-0572-x PubMed Takaya Y, Yoshihara F, Yokoyama H, Kanzaki H, Kitakaze M, Goto Y, Anzai T, Yasuda S, Ogawa H, Kawano Y (2014) Impact of onset time of acute kidney injury on outcomes in patients with acute decompensated heart failure. Heart Vessels. doi:10.​1007/​s00380-014-0572-x PubMed
3.
Zurück zum Zitat Smilde TD, Hillege HL, Navis G, Boomsma F, de Zeeuw D, van Veldhuisen DJ (2004) Impaired renal function in patients with ischemic and nonischemic chronic heart failure: association with neurohormonal activation and survival. Am Heart J 148:165–172CrossRefPubMed Smilde TD, Hillege HL, Navis G, Boomsma F, de Zeeuw D, van Veldhuisen DJ (2004) Impaired renal function in patients with ischemic and nonischemic chronic heart failure: association with neurohormonal activation and survival. Am Heart J 148:165–172CrossRefPubMed
4.
Zurück zum Zitat Smith GL, Lichtman JH, Bracken MB, Shlipak MG, Phillips CO, DiCapua P, Krumholz HM (2006) Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol 47:1987–1996CrossRefPubMed Smith GL, Lichtman JH, Bracken MB, Shlipak MG, Phillips CO, DiCapua P, Krumholz HM (2006) Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol 47:1987–1996CrossRefPubMed
5.
Zurück zum Zitat Cowie MR, Komajda M, Murray-Thomas T, Underwood J, Ticho B (2006) Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH). Eur Heart J 27:1216–1222CrossRefPubMed Cowie MR, Komajda M, Murray-Thomas T, Underwood J, Ticho B (2006) Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH). Eur Heart J 27:1216–1222CrossRefPubMed
6.
Zurück zum Zitat Hillege HL, Girbes AR, de Kam PJ, Boomsma F, de Zeeuw D, Charlesworth A, Hampton JR, van Veldhuisen DJ (2000) Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 102:203–210CrossRefPubMed Hillege HL, Girbes AR, de Kam PJ, Boomsma F, de Zeeuw D, Charlesworth A, Hampton JR, van Veldhuisen DJ (2000) Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 102:203–210CrossRefPubMed
7.
Zurück zum Zitat Hillege HL, Nitsch D, Pfeffer MA, Swedberg K, McMurray JJ, Yusuf S, Granger CB, Michelson EL, Ostergren J, Cornel JH, de Zeeuw D, Pocock S, van Veldhuisen DJ (2006) Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 113:671–678CrossRefPubMed Hillege HL, Nitsch D, Pfeffer MA, Swedberg K, McMurray JJ, Yusuf S, Granger CB, Michelson EL, Ostergren J, Cornel JH, de Zeeuw D, Pocock S, van Veldhuisen DJ (2006) Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 113:671–678CrossRefPubMed
8.
Zurück zum Zitat Nohria A, Hasselblad V, Stebbins A, Pauly DF, Fonarow GC, Shah M, Yancy CW, Califf RM, Stevenson LW, Hill JA (2008) Cardiorenal interactions: insights from the ESCAPE trial. J Am Coll Cardiol 51:1268–1274CrossRefPubMed Nohria A, Hasselblad V, Stebbins A, Pauly DF, Fonarow GC, Shah M, Yancy CW, Califf RM, Stevenson LW, Hill JA (2008) Cardiorenal interactions: insights from the ESCAPE trial. J Am Coll Cardiol 51:1268–1274CrossRefPubMed
9.
Zurück zum Zitat Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM (2006) Secular trends in renal dysfunction and outcomes in hospitalized heart failure patients. J Card Fail 12:257–262CrossRefPubMed Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM (2006) Secular trends in renal dysfunction and outcomes in hospitalized heart failure patients. J Card Fail 12:257–262CrossRefPubMed
10.
Zurück zum Zitat Ljungman S, Laragh JH, Cody RJ (1990) Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function. Drugs 39(4):10–21 (discussion 22–24) CrossRefPubMed Ljungman S, Laragh JH, Cody RJ (1990) Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function. Drugs 39(4):10–21 (discussion 22–24) CrossRefPubMed
11.
Zurück zum Zitat Firth JD, Raine AE, Ledingham JG (1988) Raised venous pressure: a direct cause of renal sodium retention in oedema? Lancet 1:1033–1035CrossRefPubMed Firth JD, Raine AE, Ledingham JG (1988) Raised venous pressure: a direct cause of renal sodium retention in oedema? Lancet 1:1033–1035CrossRefPubMed
12.
Zurück zum Zitat Gnanaraj JF, von Haehling S, Anker SD, Raj DS, Radhakrishnan J (2013) The relevance of congestion in the cardio-renal syndrome. Kidney Int 83:384–391CrossRef Gnanaraj JF, von Haehling S, Anker SD, Raj DS, Radhakrishnan J (2013) The relevance of congestion in the cardio-renal syndrome. Kidney Int 83:384–391CrossRef
13.
Zurück zum Zitat Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, Young JB, Tang WH (2009) Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 53:589–596CrossRefPubMedPubMedCentral Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, Young JB, Tang WH (2009) Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 53:589–596CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Testani JM, Khera AV, St John Sutton MG, Keane MG, Wiegers SE, Shannon RP, Kirkpatrick JN (2010) Effect of right ventricular function and venous congestion on cardiorenal interactions during the treatment of decompensated heart failure. Am J Cardiol 105:511–516CrossRefPubMedPubMedCentral Testani JM, Khera AV, St John Sutton MG, Keane MG, Wiegers SE, Shannon RP, Kirkpatrick JN (2010) Effect of right ventricular function and venous congestion on cardiorenal interactions during the treatment of decompensated heart failure. Am J Cardiol 105:511–516CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Anselmi A, Abbate A, Girola F, Nasso G, Biondi-Zoccai GG, Possati G, Gaudino M (2004) Myocardial ischemia, stunning, inflammation, and apoptosis during cardiac surgery: a review of evidence. Eur J Cardiothorac Surg 25:304–311CrossRefPubMed Anselmi A, Abbate A, Girola F, Nasso G, Biondi-Zoccai GG, Possati G, Gaudino M (2004) Myocardial ischemia, stunning, inflammation, and apoptosis during cardiac surgery: a review of evidence. Eur J Cardiothorac Surg 25:304–311CrossRefPubMed
16.
Zurück zum Zitat Welke KF, Diggs BS, Karamlou T, Ungerleider RM (2009) Comparison of pediatric cardiac surgical mortality rates from national administrative data to contemporary clinical standards. Ann Thorac Surg 87:216–222 (discussion 222–223) CrossRefPubMed Welke KF, Diggs BS, Karamlou T, Ungerleider RM (2009) Comparison of pediatric cardiac surgical mortality rates from national administrative data to contemporary clinical standards. Ann Thorac Surg 87:216–222 (discussion 222–223) CrossRefPubMed
17.
Zurück zum Zitat Price JF, Mott AR, Dickerson HA, Jefferies JL, Nelson DP, Chang AC, O’Brian Smith E, Towbin JA, Dreyer WJ, Denfield SW, Goldstein SL (2008) Worsening renal function in children hospitalized with decompensated heart failure: evidence for a pediatric cardiorenal syndrome? Pediatr Crit Care Med 9:279–284CrossRefPubMed Price JF, Mott AR, Dickerson HA, Jefferies JL, Nelson DP, Chang AC, O’Brian Smith E, Towbin JA, Dreyer WJ, Denfield SW, Goldstein SL (2008) Worsening renal function in children hospitalized with decompensated heart failure: evidence for a pediatric cardiorenal syndrome? Pediatr Crit Care Med 9:279–284CrossRefPubMed
18.
Zurück zum Zitat Smith GL, Vaccarino V, Kosiborod M, Lichtman JH, Cheng S, Watnick SG, Krumholz HM (2003) Worsening renal function: what is a clinically meaningful change in creatinine during hospitalization with heart failure? J Card Fail 9:13–25CrossRefPubMed Smith GL, Vaccarino V, Kosiborod M, Lichtman JH, Cheng S, Watnick SG, Krumholz HM (2003) Worsening renal function: what is a clinically meaningful change in creatinine during hospitalization with heart failure? J Card Fail 9:13–25CrossRefPubMed
19.
Zurück zum Zitat Weinfeld MS, Chertow GM, Stevenson LW (1999) Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure. Am Heart J 138:285–290CrossRefPubMed Weinfeld MS, Chertow GM, Stevenson LW (1999) Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure. Am Heart J 138:285–290CrossRefPubMed
20.
Zurück zum Zitat Rajagopal SK, Yarlagadda VV, Thiagarajan RR, Singh TP, Givertz MM, Almond CS (2012) Pediatric heart failure and worsening renal function: association with outcomes after heart transplantation. J Heart Lung Transplant 31:252–258CrossRefPubMed Rajagopal SK, Yarlagadda VV, Thiagarajan RR, Singh TP, Givertz MM, Almond CS (2012) Pediatric heart failure and worsening renal function: association with outcomes after heart transplantation. J Heart Lung Transplant 31:252–258CrossRefPubMed
21.
Zurück zum Zitat Blinder JJ, Goldstein SL, Lee VV, Baycroft A, Fraser CD, Nelson D, Jefferies JL (2012) Congenital heart surgery in infants: effects of acute kidney injury on outcomes. J Thorac Cardiovasc Surg 143:368–374CrossRefPubMed Blinder JJ, Goldstein SL, Lee VV, Baycroft A, Fraser CD, Nelson D, Jefferies JL (2012) Congenital heart surgery in infants: effects of acute kidney injury on outcomes. J Thorac Cardiovasc Surg 143:368–374CrossRefPubMed
22.
Zurück zum Zitat Aydin SI, Seiden HS, Blaufox AD, Parnell VA, Choudhury T, Punnoose A, Schneider J (2012) Acute kidney injury after surgery for congenital heart disease. Ann Thorac Surg 94:1589–1595CrossRefPubMed Aydin SI, Seiden HS, Blaufox AD, Parnell VA, Choudhury T, Punnoose A, Schneider J (2012) Acute kidney injury after surgery for congenital heart disease. Ann Thorac Surg 94:1589–1595CrossRefPubMed
23.
Zurück zum Zitat Pedersen K (2012) Acute kidney injury in children undergoing surgery for congenital heart disease. Eur J Pediatr Surg 22:426–433CrossRefPubMed Pedersen K (2012) Acute kidney injury in children undergoing surgery for congenital heart disease. Eur J Pediatr Surg 22:426–433CrossRefPubMed
24.
Zurück zum Zitat Pedersen KR, Povlsen JV, Christensen S, Pedersen J, Hjortholm K, Larsen SH, Hjortdal VE (2007) Risk factors for acute renal failure requiring dialysis after surgery for congenital heart disease in children. Acta Anaesthesiol Scand 51:1344–1349CrossRefPubMed Pedersen KR, Povlsen JV, Christensen S, Pedersen J, Hjortholm K, Larsen SH, Hjortdal VE (2007) Risk factors for acute renal failure requiring dialysis after surgery for congenital heart disease in children. Acta Anaesthesiol Scand 51:1344–1349CrossRefPubMed
25.
Zurück zum Zitat Okumura S, Sakakibara M, Hayashida R, Jinno Y, Tanaka A, Okada K, Hayashi M, Ishii H, Murohara T (2014) Accelerated decline in renal function after acute myocardial infarction in patients with high low-density lipoprotein-cholesterol to high-density lipoprotein-cholesterol ratio. Heart Vessels 29:7–14CrossRefPubMed Okumura S, Sakakibara M, Hayashida R, Jinno Y, Tanaka A, Okada K, Hayashi M, Ishii H, Murohara T (2014) Accelerated decline in renal function after acute myocardial infarction in patients with high low-density lipoprotein-cholesterol to high-density lipoprotein-cholesterol ratio. Heart Vessels 29:7–14CrossRefPubMed
26.
Zurück zum Zitat Kurishima C, Masutani S, Kuwata S, Iwamoto Y, Saiki H, Ishido H, Tamura M, Senzaki H (2015) Cystatin C and body surface area are major determinants of the ratio of N-terminal pro-brain natriuretic peptide to brain natriuretic peptide levels in children. J Cardiol 66:175–180CrossRefPubMed Kurishima C, Masutani S, Kuwata S, Iwamoto Y, Saiki H, Ishido H, Tamura M, Senzaki H (2015) Cystatin C and body surface area are major determinants of the ratio of N-terminal pro-brain natriuretic peptide to brain natriuretic peptide levels in children. J Cardiol 66:175–180CrossRefPubMed
Metadaten
Titel
Prevalence, implication, and determinants of worsening renal function after surgery for congenital heart disease
verfasst von
Hirofumi Saiki
Seiko Kuwata
Clara Kurishima
Yoichi Iwamoto
Hirotaka Ishido
Satoshi Masutani
Hideaki Senzaki
Publikationsdatum
13.08.2015
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 8/2016
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-015-0730-9

Weitere Artikel der Ausgabe 8/2016

Heart and Vessels 8/2016 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.